Corrigendum to "Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study".

IF 5 3区医学 Q2 PHARMACOLOGY & PHARMACY

Therapeutic Advances in Psychopharmacology Pub Date : 2026-05-19 eCollection Date: 2026-01-01 DOI:10.1177/20451253261452482

引用次数: 0

Abstract

[This corrects the article DOI: 10.1177/20451253261437597.].

查看原文本刊更多论文

“鼻内艾氯胺酮治疗难治性抑郁症：一项5年观察性研究的长期给药模式和临床结果”的勘误表。

[这更正了文章DOI: 10.1177/20451253261437597.]

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Therapeutic Advances in Psychopharmacology Multiple-

CiteScore

7.90

自引率

2.40%

发文量

审稿时长

10 weeks

期刊介绍： Therapeutic Advances in Psychopharmacology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of psychopharmacology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in psychopharmacology, providing a forum in print and online for publishing the highest quality articles in this area.